NEW YORK (Reuters) - A divided federal appeals court on Monday threw out the conviction of a sales representative for promoting off-label use of a prescription drug, a ruling that ...
Read more
NEW YORK (Reuters) - Pfizer Inc agreed to pay $67.5 million to settle a class-action lawsuit by former Wyeth Inc shareholders who said they were misled about risks associated with ...
Read more
(Reuters) - A federal judge has granted class-action status to former Wyeth Inc shareholders who accused the company, now part of Pfizer Inc, of misleading them about risks associated with ...
Read more